Ivan I Kostroma (Ivan Kostroma)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Chronic Kidney Disease

Prognostic Factors

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anna S Zhuk, Elena I Stepchenkova, Irina V Zotova, Olesya B Belopolskaya, Youri I Pavlov, Ivan I Kostroma, Sergey V Gritsaev, Anna Y Aksenova
G-Quadruplex Forming DNA Sequence Context Is Enriched around Points of Somatic Mutations in a Subset of Multiple Myeloma Patients. International journal of molecular sciences 25 (10) (2024)
Anna S Zhuk, Elena I Stepchenkova, Irina V Zotova, Olesya B Belopolskaya, Youri I Pavlov, Ivan I Kostroma, Sergey V Gritsaev, Anna Y Aksenova
G-Quadruplex Forming DNA Sequence Context Is Enriched around Points of Somatic Mutations in a Subset of Multiple Myeloma Patients. International journal of molecular sciences 25 (10) (2024)
Natella I Enukashvily, Liubov A Belik, Natalia Yuryevna Semenova, Ivan I Kostroma, Ekaterina V Motyko, Sergey V Gritsaev, Stanislav S Bessmeltsev, Sergey V Sidorkevich, Irina S Martynkevich
Transcription of WNT Genes in Hematopoietic Niche's Mesenchymal Stem Cells in Multiple Myeloma Patients with Different Responses to Treatment. Genes 14 (5) (2023)
Natella I Enukashvily, Natalia Yuryevna Semenova, Anna V Chubar, Dmitry I Ostromyshenskii, Ekaterina A Gushcha, Sergey V Gritsaev, Stanislav S Bessmeltsev, Viktor I Rugal, Egor M Prikhodko, Ivan I Kostroma, Anastasia Zherniakova, Anastasia V Kotova, Liubov A Belik, Alexander Shumeev, Irina I Maslennikova, Dmitry I Ivolgin
Pericentromeric Non-Coding DNA Transcription Is Associated with Niche Impairment in Patients with Ineffective or Partially Effective Multiple Myeloma Treatment. International journal of molecular sciences 23 (6) (2022)
Anna Y Aksenova, Anna S Zhuk, Artem G Lada, Irina V Zotova, Elena I Stepchenkova, Ivan I Kostroma, Sergey V Gritsaev, Youri I Pavlov
Genome Instability in Multiple Myeloma: Facts and Factors. Cancers 13 (23) (2021)